Clinical Trial Update: Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SAL-0951 with recombinant human erythropoietin in anemic patients on maintenance hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Recombinant human erythropoietin (erythropoietin)
• SAL-0951

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Anemia | Phase 3 | Status: COMPLETED